JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Molecular Endocrinology (2005) 35 231-243    DOI: 10.1677/jme.1.01840
© 2005 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindberg, K
Right arrow Articles by Billestrup, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindberg, K
Right arrow Articles by Billestrup, N

Regulation of pancreatic ß-cell mass and proliferation by SOCS-3

K Lindberg1,*, S G Rønn1,3,*, D Tornehave2, H Richter1, J A Hansen1, J Rømer2, M Jackerott4 and N Billestrup1,3

1 Department of Signal Transduction,
2 Department of Pharmacology, Novo Nordisk A/S, Bagsværd, Denmark
3 Steno Diabetes Center, Niels Steensens Vej 6, DK-2820 Gentofte, Denmark
4 Institute of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark

(Requests for offprints should be addressed to N Billestrup at Steno Diabetes Center, Gentofte, Denmark; Email: nbil{at}steno.dk)

(Present address of J Rømer is: Finsen Laboratory, Rigshospitalet, Denmark)

* (K Lindberg and S G Ronn contributed equally to this paper)

Growth hormone and prolactin are important growth factors for pancreatic ß-cells. The effects exerted by these hormones on proliferation and on insulin synthesis and secretion in ß-cells are largely mediated through the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway. Suppressors of cytokine signaling (SOCS) proteins are specific inhibitors of the JAK/STAT pathway acting through a negative-feedback loop. To investigate in vivo effects of SOCS-3 in growth hormone (GH)/prolactin signaling in ß-cells we generated transgenic mice with ß-cell-specific overexpression of SOCS-3. The relative ß-cell proliferation and volume in the mice were measured by morphometry. ß-Cell volume of transgenic female mice was reduced by over 30% compared with ß-cell volume in wild-type female mice. Stimulation of transgenic islets in vitro with GH showed a reduced tyrosine phosphorylation of STAT-5 when compared with wild-type islets. Transduction of primary islet cultures with adenoviruses expressing various SOCS proteins followed by stimulation with GH or glucagon-like peptide-1 (GLP-1) revealed that SOCS-3 inhibited GH- but not GLP-1-mediated islet cell proliferation, indicating that the decreased ß-cell volume observed in female transgenic mice could be caused by an inhibition of GH-induced ß-cell proliferation by SOCS-3. In spite of the reduced ß-cell volume the transgenic female mice exhibited enhanced glucose tolerance compared with wild-type littermates following an oral glucose-tolerance test. Together these data suggest that SOCS-3 modulates cytokine signaling in pancreatic ß-cells and therefore potentially could be a candidate target for development of new treatment strategies for diabetes.




This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman
Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation
Endocr. Rev., August 1, 2008; 29(5): 603 - 630.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
S. Park, S. Hong, J. Lee, S. Sung, and S. Kim
Chlorpromazine attenuates pancreatic {beta}-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation
J Psychopharmacol, July 1, 2008; 22(5): 522 - 531.
[Abstract] [PDF]

Home page
 JEMHome page
K. J. Riehle, J. S. Campbell, R. S. McMahan, M. M. Johnson, R. P. Beyer, T. K. Bammler, and N. Fausto
Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3
J. Exp. Med., January 21, 2008; 205(1): 91 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Ma, Y. Gong, V. Patel, C. M. Karner, E. Fischer, T. Hiesberger, T. J. Carroll, M. Pontoglio, and P. Igarashi
Mutations of HNF-1 inhibit epithelial morphogenesis through dysregulation of SOCS-3
PNAS, December 18, 2007; 104(51): 20386 - 20391.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen
Diabetes and Suppressors of Cytokine Signaling Proteins
Diabetes, February 1, 2007; 56(2): 541 - 548.
[Full Text] [PDF]

Home page
 DiabetesHome page
M. Jackerott, A. Moldrup, P. Thams, E. D. Galsgaard, J. Knudsen, Y. C. Lee, and J. H. Nielsen
STAT5 Activity in Pancreatic {beta}-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes.
Diabetes, October 1, 2006; 55(10): 2705 - 2712.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.